血漿プロテアーゼC1阻害剤の世界市場 2024-2028

概要

血漿プロテアーゼC1阻害剤市場は、2023年から2028年にかけて20億米ドル、予測期間中のCAGRは7.55%で成長すると予測されています。

当レポートでは、血漿プロテアーゼC1阻害剤市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、血漿プロテアーゼC1阻害剤における研究開発の増加、血漿プロテアーゼC1インヒビターの製品承認/上市の増加、血漿プロテアーゼC1阻害剤における技術進歩などによって牽引されています。

本調査では、ブラジキニンB2受容体拮抗薬の採用拡大が、今後数年間の血漿プロテアーゼC1阻害剤市場成長を牽引する主要因の一つであると特定しています。また、血漿プロテアーゼC1阻害剤製品の開発や入手のしやすさ、患者向けの高品質な医療ソリューションのイントロダクションおける有利な政府のイニシアチブは、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 血漿プロテアーゼC1阻害剤の世界市場 2018-2022
• エンドユーザーセグメント分析 2018-2022
• 製品セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 病院薬局：市場規模と予測 2023-2028
• 小売薬局：市場規模と予測 2023-2028
• オンライン薬局：市場規模と予測 2023-2028
• 市場機会：エンドユーザー別

第7章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• 凍結乾燥：市場規模と予測 2023-2028
• 注射可能：市場規模と予測 2023-2028
• 市場機会：製品別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 日本：市場規模と予測 2023-2028
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca Plc
• Bausch Health Companies Inc.
• Bio Techne Corp.
• BioCryst Pharmaceuticals Inc.
• Biosynth Ltd.
• Bristol Myers Squibb Co.
• Cayman Chemical
• CSL Ltd.
• Fresenius SE and Co. KGaA
• Ionis Pharmaceuticals Inc.
• KalVista Pharmaceuticals Inc.
• Sino Biological Inc.
• Takeda Pharmaceutical Co. Ltd.
• Thermo Fisher Scientific Inc.
• Vertex Pharmaceuticals Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Market Segmentation by Product
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global plasma protease c1 inhibitor market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by End-user ($ billion)
• Exhibits47: Data Table on Market opportunity by End-user ($ billion)
• Exhibits48: Chart on Product - Market share 2023-2028 (%)
• Exhibits49: Data Table on Product - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by Product
• Exhibits51: Data Table on Comparison by Product
• Exhibits52: Chart on Lyophilized - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Lyophilized - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Lyophilized - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Lyophilized - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by Product ($ billion)
• Exhibits61: Data Table on Market opportunity by Product ($ billion)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ billion)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: AstraZeneca Plc - Overview
• Exhibits112: AstraZeneca Plc - Product / Service
• Exhibits113: AstraZeneca Plc - Key news
• Exhibits114: AstraZeneca Plc - Key offerings
• Exhibits115: Bausch Health Companies Inc. - Overview
• Exhibits116: Bausch Health Companies Inc. - Business segments
• Exhibits117: Bausch Health Companies Inc. - Key news
• Exhibits118: Bausch Health Companies Inc. - Key offerings
• Exhibits119: Bausch Health Companies Inc. - Segment focus
• Exhibits120: Bio Techne Corp. - Overview
• Exhibits121: Bio Techne Corp. - Business segments
• Exhibits122: Bio Techne Corp. - Key offerings
• Exhibits123: Bio Techne Corp. - Segment focus
• Exhibits124: BioCryst Pharmaceuticals Inc. - Overview
• Exhibits125: BioCryst Pharmaceuticals Inc. - Product / Service
• Exhibits126: BioCryst Pharmaceuticals Inc. - Key offerings
• Exhibits127: Biosynth Ltd. - Overview
• Exhibits128: Biosynth Ltd. - Product / Service
• Exhibits129: Biosynth Ltd. - Key offerings
• Exhibits130: Bristol Myers Squibb Co. - Overview
• Exhibits131: Bristol Myers Squibb Co. - Product / Service
• Exhibits132: Bristol Myers Squibb Co. - Key news
• Exhibits133: Bristol Myers Squibb Co. - Key offerings
• Exhibits134: Cayman Chemical - Overview
• Exhibits135: Cayman Chemical - Product / Service
• Exhibits136: Cayman Chemical - Key offerings
• Exhibits137: CSL Ltd. - Overview
• Exhibits138: CSL Ltd. - Business segments
• Exhibits139: CSL Ltd. - Key offerings
• Exhibits140: CSL Ltd. - Segment focus
• Exhibits141: Fresenius SE and Co. KGaA - Overview
• Exhibits142: Fresenius SE and Co. KGaA - Business segments
• Exhibits143: Fresenius SE and Co. KGaA - Key news
• Exhibits144: Fresenius SE and Co. KGaA - Key offerings
• Exhibits145: Fresenius SE and Co. KGaA - Segment focus
• Exhibits146: Ionis Pharmaceuticals Inc. - Overview
• Exhibits147: Ionis Pharmaceuticals Inc. - Business segments
• Exhibits148: Ionis Pharmaceuticals Inc. - Key news
• Exhibits149: Ionis Pharmaceuticals Inc. - Key offerings
• Exhibits150: Ionis Pharmaceuticals Inc. - Segment focus
• Exhibits151: KalVista Pharmaceuticals Inc. - Overview
• Exhibits152: KalVista Pharmaceuticals Inc. - Product / Service
• Exhibits153: KalVista Pharmaceuticals Inc. - Key offerings
• Exhibits154: Sino Biological Inc. - Overview
• Exhibits155: Sino Biological Inc. - Product / Service
• Exhibits156: Sino Biological Inc. - Key offerings
• Exhibits157: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits158: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits159: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits160: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits161: Thermo Fisher Scientific Inc. - Overview
• Exhibits162: Thermo Fisher Scientific Inc. - Business segments
• Exhibits163: Thermo Fisher Scientific Inc. - Key news
• Exhibits164: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits165: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits166: Vertex Pharmaceuticals Inc. - Overview
• Exhibits167: Vertex Pharmaceuticals Inc. - Product / Service
• Exhibits168: Vertex Pharmaceuticals Inc. - Key offerings
• Exhibits169: Inclusions checklist
• Exhibits170: Exclusions checklist
• Exhibits171: Currency conversion rates for US$
• Exhibits172: Research methodology
• Exhibits173: Validation techniques employed for market sizing
• Exhibits174: Information sources
• Exhibits175: List of abbreviations

Abstract

The plasma protease C1 inhibitor market is forecasted to grow by USD 2.00 bn during 2023-2028, accelerating at a CAGR of 7.55% during the forecast period. The report on the plasma protease C1 inhibitor market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing research and development in plasma protease C1 inhibitor, increasing product approvals/launches of plasma protease C1inhibitor, and technological advancements in plasma protease C1 inhibitor.

Technavio's plasma protease C1 inhibitor market is segmented as below:

By End-user

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

By Product

• Lyophilized
• Injectable

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing adoption of bradykinin B2 receptor antagonist as one of the prime reasons driving the plasma protease C1 inhibitor market growth during the next few years. Also, favorable government initiatives in development and accessibility of plasma protease C1 inhibitor products and introduction of high-quality medical solutions for patients will lead to sizable demand in the market.

The report on the plasma protease C1 inhibitor market covers the following areas:

• Plasma protease C1 inhibitor market sizing
• Plasma protease C1inhibitor market forecast
• Plasma protease C1 inhibitor market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading plasma protease C1 inhibitor market vendors that include AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bio Techne Corp., BioCryst Pharmaceuticals Inc., Biosynth Ltd., Bristol Myers Squibb Co., Cayman Chemical, CSL Ltd., FibroGen Inc., Fresenius SE and Co. KGaA, Gilead Sciences Inc., Ionis Pharmaceuticals Inc., KalVista Pharmaceuticals Inc., Merck KGaA, Novartis AG, Pharming Group NV, Sino Biological Inc., Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc.. Also, the plasma protease C1 inhibitor market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global plasma protease C1 inhibitor market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global plasma protease c1 inhibitor market 2018 - 2022 ($ billion)
• 4.2 End-user Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
• 4.3 Product Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
• Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
• Exhibit 32: Chart on Comparison by End-user
• Exhibit 33: Data Table on Comparison by End-user
• 6.3 Hospital pharmacy - Market size and forecast 2023-2028
• Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
• 6.4 Retail pharmacy - Market size and forecast 2023-2028
• Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
• 6.5 Online pharmacy - Market size and forecast 2023-2028
• Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
• 6.6 Market opportunity by End-user
• Exhibit 46: Market opportunity by End-user ($ billion)
• Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Product

• 7.1 Market segments
• Exhibit 48: Chart on Product - Market share 2023-2028 (%)
• Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
• 7.2 Comparison by Product
• Exhibit 50: Chart on Comparison by Product
• Exhibit 51: Data Table on Comparison by Product
• 7.3 Lyophilized - Market size and forecast 2023-2028
• Exhibit 52: Chart on Lyophilized - Market size and forecast 2023-2028 ($ billion)
• Exhibit 53: Data Table on Lyophilized - Market size and forecast 2023-2028 ($ billion)
• Exhibit 54: Chart on Lyophilized - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Lyophilized - Year-over-year growth 2023-2028 (%)
• 7.4 Injectable - Market size and forecast 2023-2028
• Exhibit 56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
• Exhibit 57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
• Exhibit 58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Product
• Exhibit 60: Market opportunity by Product ($ billion)
• Exhibit 61: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Germany - Market size and forecast 2023-2028
• Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.9 UK - Market size and forecast 2023-2028
• Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.10 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 AstraZeneca Plc
• Exhibit 111: AstraZeneca Plc - Overview
• Exhibit 112: AstraZeneca Plc - Product / Service
• Exhibit 113: AstraZeneca Plc - Key news
• Exhibit 114: AstraZeneca Plc - Key offerings
• 12.4 Bausch Health Companies Inc.
• Exhibit 115: Bausch Health Companies Inc. - Overview
• Exhibit 116: Bausch Health Companies Inc. - Business segments
• Exhibit 117: Bausch Health Companies Inc. - Key news
• Exhibit 118: Bausch Health Companies Inc. - Key offerings
• Exhibit 119: Bausch Health Companies Inc. - Segment focus
• 12.5 Bio Techne Corp.
• Exhibit 120: Bio Techne Corp. - Overview
• Exhibit 121: Bio Techne Corp. - Business segments
• Exhibit 122: Bio Techne Corp. - Key offerings
• Exhibit 123: Bio Techne Corp. - Segment focus
• 12.6 BioCryst Pharmaceuticals Inc.
• Exhibit 124: BioCryst Pharmaceuticals Inc. - Overview
• Exhibit 125: BioCryst Pharmaceuticals Inc. - Product / Service
• Exhibit 126: BioCryst Pharmaceuticals Inc. - Key offerings
• 12.7 Biosynth Ltd.
• Exhibit 127: Biosynth Ltd. - Overview
• Exhibit 128: Biosynth Ltd. - Product / Service
• Exhibit 129: Biosynth Ltd. - Key offerings
• 12.8 Bristol Myers Squibb Co.
• Exhibit 130: Bristol Myers Squibb Co. - Overview
• Exhibit 131: Bristol Myers Squibb Co. - Product / Service
• Exhibit 132: Bristol Myers Squibb Co. - Key news
• Exhibit 133: Bristol Myers Squibb Co. - Key offerings
• 12.9 Cayman Chemical
• Exhibit 134: Cayman Chemical - Overview
• Exhibit 135: Cayman Chemical - Product / Service
• Exhibit 136: Cayman Chemical - Key offerings
• 12.10 CSL Ltd.
• Exhibit 137: CSL Ltd. - Overview
• Exhibit 138: CSL Ltd. - Business segments
• Exhibit 139: CSL Ltd. - Key offerings
• Exhibit 140: CSL Ltd. - Segment focus
• 12.11 Fresenius SE and Co. KGaA
• Exhibit 141: Fresenius SE and Co. KGaA - Overview
• Exhibit 142: Fresenius SE and Co. KGaA - Business segments
• Exhibit 143: Fresenius SE and Co. KGaA - Key news
• Exhibit 144: Fresenius SE and Co. KGaA - Key offerings
• Exhibit 145: Fresenius SE and Co. KGaA - Segment focus
• 12.12 Ionis Pharmaceuticals Inc.
• Exhibit 146: Ionis Pharmaceuticals Inc. - Overview
• Exhibit 147: Ionis Pharmaceuticals Inc. - Business segments
• Exhibit 148: Ionis Pharmaceuticals Inc. - Key news
• Exhibit 149: Ionis Pharmaceuticals Inc. - Key offerings
• Exhibit 150: Ionis Pharmaceuticals Inc. - Segment focus
• 12.13 KalVista Pharmaceuticals Inc.
• Exhibit 151: KalVista Pharmaceuticals Inc. - Overview
• Exhibit 152: KalVista Pharmaceuticals Inc. - Product / Service
• Exhibit 153: KalVista Pharmaceuticals Inc. - Key offerings
• 12.14 Sino Biological Inc.
• Exhibit 154: Sino Biological Inc. - Overview
• Exhibit 155: Sino Biological Inc. - Product / Service
• Exhibit 156: Sino Biological Inc. - Key offerings
• 12.15 Takeda Pharmaceutical Co. Ltd.
• Exhibit 157: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 158: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 159: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 160: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 12.16 Thermo Fisher Scientific Inc.
• Exhibit 161: Thermo Fisher Scientific Inc. - Overview
• Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 163: Thermo Fisher Scientific Inc. - Key news
• Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus
• 12.17 Vertex Pharmaceuticals Inc.
• Exhibit 166: Vertex Pharmaceuticals Inc. - Overview
• Exhibit 167: Vertex Pharmaceuticals Inc. - Product / Service
• Exhibit 168: Vertex Pharmaceuticals Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 169: Inclusions checklist
• Exhibit 170: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 171: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 172: Research methodology
• Exhibit 173: Validation techniques employed for market sizing
• Exhibit 174: Information sources
• 13.5 List of abbreviations
• Exhibit 175: List of abbreviations